Biocon Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
368.00
1,429.00
1,297.00
643.00
771.00
846.00
Adjustment
3,000.00
2,168.00
2,583.00
1,939.00
1,456.00
931.00
Changes In working Capital
-1,132.00
923.00
-635.00
-501.00
-789.00
-423.00
Cash Flow after changes in Working Capital
2,236.00
4,520.00
3,246.00
2,081.00
1,438.00
1,353.00
Cash Flow from Operating Activities
1,994.00
4,061.00
2,953.00
1,852.00
1,176.00
1,159.00
Cash Flow from Investing Activities
-1,882.00
-202.00
-1,001.00
-14,260.00
-1,662.00
-3,651.00
Cash Flow from Financing Activities
-923.00
-1,854.00
-2,332.00
13,048.00
242.00
2,564.00
Net Cash Inflow / Outflow
-812.00
2,004.00
-380.00
641.00
-243.00
72.00
Opening Cash & Cash Equivalents
2,923.00
919.00
1,299.00
653.00
897.00
824.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
2,111.00
2,923.00
919.00
1,294.00
653.00
897.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Biocon
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
368.8
2870.89
-2,502.00
-87.15%
Adjustment
3000
136.33
2,864.00
2100.54%
Changes In working Capital
-1132.2
-415.17
-717.00
-172.71%
Cash Flow after changes in Working Capital
2236.6
2592.05
-356.00
-13.71%
Cash Flow from Operating Activities
1994
1963.03
31.00
1.58%
Cash Flow from Investing Activities
-1882.7
-1681.67
-201.00
-11.95%
Cash Flow from Financing Activities
-923.6
-503.4
-420.00
-83.47%
Net Cash Inflow / Outflow
-812.3
-222.04
-590.00
-265.83%
Opening Cash & Cash Equivalents
2923.8
-120.09
3,043.00
2534.67%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
2111.5
-342.13
2,453.00
717.16%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -50.90% vs 37.49% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
1,994.00
4,061.20
-50.90%